Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
IB Pharmaceuticals Inc. See All Filings	D	2018-02-12 13:57:55 UTC
Amount To Be Raised $36,316,200 Associated Brokers / Dealers H.C. Wainwright & Co., LLC and GP Nurmenkari Inc. CIK Number 0001666690 Filed Document 0001666690-18-000004 Exclusions or Exemptions 506b Accepted Date 2018-02-12 13:57:55 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business NORTH CAROLINA Revenue or Assets Decline to Disclose Type of Security Equity
IB Pharmaceuticals Inc. See All Filings	D	2018-02-12 13:19:03 UTC
Amount To Be Raised $4,800,000 Associated Brokers / Dealers N/A CIK Number 0001666690 Filed Document 0001666690-18-000003 Exclusions or Exemptions 506b Accepted Date 2018-02-12 13:19:03 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business NORTH CAROLINA Revenue or Assets Decline to Disclose Type of Security Debt
Innovate Biopharmaceuticals Inc. See All Filings	D	2017-12-04 16:03:51 UTC
Amount To Be Raised $2,000,000 Associated Brokers / Dealers N/A CIK Number 0001666690 Filed Document 0001666690-17-000002 Exclusions or Exemptions 506b Accepted Date 2017-12-04 16:03:51 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business NORTH CAROLINA Revenue or Assets Decline to Disclose Type of Security Debt
Innovate Biopharmaceuticals Inc. See All Filings	D	2017-05-11 16:42:05 UTC
Amount To Be Raised $5,000,000 Associated Brokers / Dealers N/A CIK Number 0001666690 Filed Document 0001666690-17-000001 Exclusions or Exemptions 506b Accepted Date 2017-05-11 16:42:05 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business NORTH CAROLINA Revenue or Assets Decline to Disclose Type of Security Debt
Innovate Biopharmaceuticals Inc. See All Filings	D/A	2016-11-09 14:30:12 UTC
Amount To Be Raised $10,000,000 Associated Brokers / Dealers N/A CIK Number 0001666690 Filed Document 0001666690-16-000002 Exclusions or Exemptions 506b Accepted Date 2016-11-09 14:30:12 UTC Type of Offering D/A Industry Pharmaceuticals Principal Place of Business NORTH CAROLINA Revenue or Assets Decline to Disclose Type of Security Debt
Innovate Biopharmaceuticals Inc. See All Filings	D	2016-02-08 00:00:00 UTC
Amount To Be Raised $5,925,000 Associated Brokers / Dealers N/A CIK Number 0001666690 Filed Document 0001666690-16-000001 Exclusions or Exemptions 506b Accepted Date 2016-02-08 00:00:00 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business NORTH CAROLINA Revenue or Assets Decline to Disclose Type of Security Debt